Venture Partner at Vivo Capital · Joined 2016
View Live Interactive Profile →Jo Shen joined Vivo Capital in 2016 as a Venture Partner. Her Vivo biography describes her as an international pharmaceutical executive with more than 40 years of industry experience. She was co-founder, President, CEO and a Board Member of ScinoPharm Taiwan, Ltd., a publicly listed process R&D and API manufacturing service provider, which she established in 1997. Before that she spent 14 years at Syntex from 1981, latterly as Corporate Vice President of Pharmaceutical Operations and Technology with responsibility for worldwide pharmaceutical manufacturing, operations and technology transfer, and earlier worked at Monsanto for eight years in technical and management roles in the synthetic fibers and semiconductor materials divisions. She is a former board member of the U.S. Pharmaceutical Manufacturer Association (PhRMA), where she chaired the Production Group. Her Vivo biography states she currently serves on a number of boards including the Development Center for Biotechnology, the Taiwan Bio Industry Organization, the China Chemical Society and the Taiwan Pharmaceutical Manufacturing Association, where she chairs the Active Pharmaceutical Ingredients Committee; these are industry and non-profit bodies rather than company boards and none could be independently confirmed, so no board seat is recorded. She holds a Ph.D. in Chemistry from Lehigh University, an M.S. in Chemistry from the University of Iowa and a B.S. in Chemical Engineering from National Taiwan University, and received a Women in Industry award from the YWCA in California.